 Cryolife NYSE:CRY was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and ... 